130 related articles for article (PubMed ID: 34751777)
1. LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial.
Meessen JMTA; Bär C; di Dona FM; Staszewsky LI; Di Giulio P; Di Tano G; Costa A; Leonardy J; Novelli D; Nicolis EB; Masson S; Pinet F; Thum T; Latini R
Clin Chem; 2021 Nov; 67(12):1721-1731. PubMed ID: 34751777
[TBL] [Abstract][Full Text] [Related]
2. Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease.
Santer L; López B; Ravassa S; Baer C; Riedel I; Chatterjee S; Moreno MU; González A; Querejeta R; Pinet F; Thum T; Díez J
Hypertension; 2019 Apr; 73(4):820-828. PubMed ID: 30686085
[TBL] [Abstract][Full Text] [Related]
3. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
[TBL] [Abstract][Full Text] [Related]
4. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
[TBL] [Abstract][Full Text] [Related]
5. QT variability index on 24-hour Holter independently predicts mortality in patients with heart failure: analysis of Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
Dobson CP; La Rovere MT; Pinna GD; Goldstein R; Olsen C; Bernardinangeli M; Veniani M; Midi P; Tavazzi L; Haigney M;
Heart Rhythm; 2011 Aug; 8(8):1237-42. PubMed ID: 21457791
[TBL] [Abstract][Full Text] [Related]
6. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
Masson S; Anand I; Favero C; Barlera S; Vago T; Bertocchi F; Maggioni AP; Tavazzi L; Tognoni G; Cohn JN; Latini R;
Circulation; 2012 Jan; 125(2):280-8. PubMed ID: 22139751
[TBL] [Abstract][Full Text] [Related]
7. n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.
La Rovere MT; Staszewsky L; Barlera S; Maestri R; Mezzani A; Midi P; Marchioli R; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
Heart Rhythm; 2013 Feb; 10(2):226-32. PubMed ID: 23107655
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.
Mantovani A; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
Metabolism; 2018 Jun; 83():205-215. PubMed ID: 29477817
[TBL] [Abstract][Full Text] [Related]
10. Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction.
Yan L; Zhang Y; Wang M; Wang L; Zhang W; Ge ZR
Exp Biol Med (Maywood); 2021 Dec; 246(24):2589-2594. PubMed ID: 34365838
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
[TBL] [Abstract][Full Text] [Related]
12. Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers.
Cosmi F; Di Giulio P; Masson S; Finzi A; Marfisi RM; Cosmi D; Scarano M; Tognoni G; Maggioni AP; Porcu M; Boni S; Cutrupi G; Tavazzi L; Latini R;
Circ Heart Fail; 2015 May; 8(3):428-37. PubMed ID: 25925415
[TBL] [Abstract][Full Text] [Related]
13. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.
Kumarswamy R; Bauters C; Volkmann I; Maury F; Fetisch J; Holzmann A; Lemesle G; de Groote P; Pinet F; Thum T
Circ Res; 2014 May; 114(10):1569-75. PubMed ID: 24663402
[TBL] [Abstract][Full Text] [Related]
14. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
Targher G; Lunardi G; Mantovani A; Meessen J; Bonapace S; Temporelli PL; Nicolis E; Novelli D; Conti A; Tavazzi L; Maggioni AP; Latini R
ESC Heart Fail; 2020 Dec; 7(6):3288-3297. PubMed ID: 32627354
[TBL] [Abstract][Full Text] [Related]
15. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ
Circulation; 2015 Dec; 132(22):e358. PubMed ID: 26621661
[No Abstract] [Full Text] [Related]
16. Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Lin GM; Hung Y; Li YH
Circulation; 2015 Dec; 132(22):e357. PubMed ID: 26621660
[No Abstract] [Full Text] [Related]
17. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF.
Sanders-van Wijk S; Masson S; Milani V; Rickenbacher P; Gorini M; Tavazzi LT; Tobler D; Rickli H; Latini R; Brunner-La Roccaenen HP;
Clin Chem; 2016 Apr; 62(4):605-16. PubMed ID: 26936932
[TBL] [Abstract][Full Text] [Related]
19. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
Finzi AA; Latini R; Barlera S; Rossi MG; Ruggeri A; Mezzani A; Favero C; Franzosi MG; Serra D; Lucci D; Bianchini F; Bernasconi R; Maggioni AP; Nicolosi G; Porcu M; Tognoni G; Tavazzi L; Marchioli R
Am Heart J; 2011 Feb; 161(2):338-343.e1. PubMed ID: 21315217
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
